CDKN2A and adenocarcinoma: In malignant gastric cancer patients, increased MKRN1 and low ARF expression is observed in well-differentiated adenocarcinoma, while low MKRN1 and high ARF expression is detected in poorly differentiated adenocarcinoma [72].